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Abstract
Continuous focused ultrasound (cFUS) has been widely used for thermal ablation of tissues, relying on continuous
exposures to generate temperatures necessary to induce coagulative necrosis. Pulsed FUS (pFUS) employs non-continuous
exposures that lower the rate of energy deposition and allow cooling to occur between pulses, thereby minimizing thermal
effects and emphasizing effects created by non-thermal mechanisms of FUS (i.e., acoustic radiation forces and acoustic
cavitation). pFUS has shown promise for a variety of applications including drug and nanoparticle delivery; however, little is
understood about the effects these exposures have on tissue, especially with regard to cellular pro-homing factors (growth
factors, cytokines, and cell adhesion molecules). We examined changes in murine hamstring muscle following pFUS or cFUS
and demonstrate that pFUS, unlike cFUS, has little effect on the histological integrity of muscle and does not induce cell
death. Infiltration of macrophages was observed 3 and 8 days following pFUS or cFUS exposures. pFUS increased expression
of several cytokines (e.g., IL-1a, IL-1b, TNFa, INFc, MIP-1a, MCP-1, and GMCSF) creating a local cytokine gradient on days 0
and 1 post-pFUS that returns to baseline levels by day 3 post-pFUS. pFUS exposures induced upregulation of other signaling
molecules (e.g., VEGF, FGF, PlGF, HGF, and SDF-1a) and cell adhesion molecules (e.g., ICAM-1 and VCAM-1) on muscle
vasculature. The observed molecular changes in muscle following pFUS may be utilized to target cellular therapies by
increasing homing to areas of pathology.
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Introduction
Focused ultrasound waves can be coupled with image guidance
(e.g. magnetic resonance imaging (MRI)), to direct thermal and
mechanical energy accurately deep within the body without
causing demonstrable effects to the intervening soft-tissues or bone
[1]. The current clinical use of focused ultrasound (FUS) exposures
is to increase the temperature of targeted tissues (to 70–80uC) to
generate coagulative necrosis and non-invasively treat uterine
fibroids and prostate tumors [2]. Presently, FUS is being
investigated in clinical trials for the treatment of other malignan-
cies such as breast tumors and gliomas [2,3]. Continuous FUS
(cFUS) exposures (1–10 seconds) are typically accompanied by an
inflammatory responses within the treated prostate tumor tissue
[3]. Biermann et al [4] found mild and chronic inflammation in
FUS-treated prostate tumors up to 180 days post FUS, but were
not able to distinguish between cFUS-induced inflammation and
tumor-associated or tumor-induced inflammation. As part of the
inflammatory process, antigen-presenting cells (APC) (e.g. den-
dritic cells, macrophages, and B lymphocytes) have been observed
at the periphery of cFUS-treated breast tumor lesions [5]. The
APCs observed after cFUS treatment resulted in increased
expression of T-cell-activating signals such as CD80 and CD86
suggesting that FUS treatment also stimulated an anti-tumor
immune response. Hu et al. [6] also observed enhanced activity of
cytotoxic lymphocytes and an increase in cells secreting tumor
specific interferon-c (INFc) as a result of cFUS exposures in MC-
38 colon adenocarcinoma tumors.
Whereas cFUS causes thermal ablation of tissue, shorter pulsed
exposures (10–50 ms/sec) provide lower rates of energy deposition
and allow cooling to occur between pulse intervals. Pulsed FUS
(pFUS) exposures, despite utilizing relatively high intensities
(1000–2000 Watts/cm
2) minimize temperature elevations in tissue
(,4–5uC) [7,8] and instead, emphasize the non-thermal effects of
FUS (i.e. acoustic cavitation and acoustic radiation forces). These
non-thermal effects have been shown to increase tissue perme-
ability and enhance delivery of drugs and genes while inducing
only minor and transient morphological changes within the
treated region [9]. pFUS exposures to the brain result in transient
disruption of the blood-brain-barrier (BBB), suggesting that this
non-invasive tool can provide spatial and temporal control over
delivery of therapeutics to brain tissue [2,10]. These exposures
may also be used for sonoporation, where transient pores are
created by the collapse of cavitating bubbles to enhance local
uptake of drugs and genes into individual cells [11]. Ultrasound-
induced cavitation may also be employed to improve tissue
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sound exposures are also presently being developed where the
energy (both thermal and nom-thermal) is used to deploy a variety
of therapeutic agents from specially formulated carriers [13].
Relatively little is known about the cellular and molecular
biological effects of pFUS exposures beyond the structural changes
that result in vascular leakage. Cellular and molecular biology of
tissues can be dramatically altered by mechanical force and stress
through the process of mechanotransduction (i.e. biological activity
in response to mechanical force) [14]. As the use of pFUS increases
in clinical applications, there is a need to better understand the
cellular and molecular consequences of depositing this form of
energy in tissues and how to harness this non-invasive technique for
novel therapies. Although pFUS is generally considered to be non-
destructive, studies have provided some insight into the mechanism
of action on sub-cellular and molecular levels (7–9). Following
targeted pFUS exposures to muscle, T2-weighted MRI demonstrat-
ed the presence of edema that coincided with enhanced delivery of
gadolinium(Gd)chelate-containingliposomesinthetargetedregions
[15]. pFUS of the muscle has been shown to create transient and
reversible myobundle displacements or spreading (gaps) due to
edema accompanied by possible disruption of the extracellular
matrix (ECM) [16]. The changes in the muscle corresponded with
improved distribution of fluorescently labeled nanoparticles injected
directly into the tissue following the exposures. Histological
examination revealed disruption of some capillaries and collagen
in the ECM, but showed intact myofiber bundles. Trans-cranial
pFUS exposures for the purpose of opening the BBB resulted in
parenchymal enhancement on post-gadolinium chelate T1-weighed
MRI [10]. pFUS performed in conjunction with intravenously-
injected microbubbles produced an indiscretelesionvolume thatwas
accompanied by transient extravasation of red blood cells (hemor-
rhage), inflammation, and macrophage infiltration into the targeted
parenchyma [10]. Ischemic or apoptotic regions were not observed
following pFUS, suggesting that the exposures were non-destructive
to brain tissue. However, in these studies the molecular biological
changes in the tissues following pFUS were not investigated.
The objectives of the current study were to characterize the
cellular and molecular alterations in muscle following pFUS
exposures with regard to local expression of cytokines, growth
factors, and integrins. Fluorescently-labeled superparamagnetic
iron oxide nanoparticles (FL-SPION) were intravenously injected
in C3H mice to label splenic macrophages in vivo three days prior
to pFUS or cFUS of the hamstring muscle. Following FUS,
animals underwent T2- and T2*-weighted MRI to detect the
presence of edema and FL-SPION-labeled cells, respectively. Mice
were euthanized at specific time points for histological, cellular,
and molecular analyses of the tissue. T2-weighted MRI revealed
the presence of significant edema in cFUS-treated muscle that
persisted through 8 days post-FUS that was not observed in pFUS-
treated muscle. T2*-weighted MRI revealed regions of low signal
intensity (hypointense voxels) up to 8 days after both cFUS and
pFUS treatment that corresponded to infiltration of SPION-
labeled macrophages in and around muscle bundles when
examined by fluorescence microscopy and Prussian blue staining.
Unlike cFUS, pFUS induced little or no apoptosis in treated
muscle. Importantly, early elevations in cytokine expression were
detected in both cFUS- and pFUS-treated muscle (0 and 1 days
post-FUS) compared to muscle in the untreated contralateral leg.
In general, cytokine levels in the treated muscle returned to
contralateral muscle levels by 3 days post-FUS. In pFUS-treated
muscle, acute and transient cytokine expression included;
interleukin 1 (IL-1a, IL-1b), tumor necrosis factor (TNFa),
monocyte chemotactic protein (MCP-1), macrophage inflamma-
tory protein (MIP-1a) in treated muscle. Accompanying the local
upregulation of cytokines in pFUS-treated muscle were also
increases in growth factors [e.g. vascular endothelial growth factor
(VEGF), fibroblast growth factor (FGF), stromal cell-derived factor
(SDF-1a)] and increased expression of the cell adhesion molecules
intercellular adhesion molecule-1 (ICAM-1) and vascular cell
adhesion molecule-1 (VCAM-1) on the muscle vasculature.
Results
Labeling of macrophages with FL-SPION in vivo
FL-SPION were intravenously administered to mice 3 days
prior FUS. On the FUS treatment day, control mice that did not
receive FUS were euthanized and tissue sections from spleens and
livers were examined for the presence of labeled macrophages by
confocal microscopy and Prussian blue staining (Figure 1A–D).
FL-SPIONs were detected predominately in the spleen. FL-
SPION fluorescence appeared in regions that were positive for
immunohistochemical (IHC) staining of the macrophage-specific
marker F4/80 (Figure 1A). By 3 days post-FUS FL-SPIONs were
visible by fluorescence microscopy and associated with F4/80
fluorescence in muscle tissue that received either pFUS or cFUS
Figure 1. Histological detection of FL-SPION in the liver and
spleen 3 days post-injection with FL-SPION, and in FUS-treated
muscle 6 days post-injection of FL-SPION and 3 days post-FUS.
A Confocal microscopy shows FL-SPION (red) in the spleen are localized
with macrophage-specific F4/80 IHC staining (green). B FL-SPION are
not as abundant in liver C Prussian Blue staining confirms FL-SPION are
predominately taken up in the spleen rather than the liver (D). FL-
SPION-labeled macrophages are detected in leg muscle after receiving
cFUS (E) and pFUS (F) exposures. Arrows indicate macrophages that are
positive for both F4/80 and FL-SPION.
doi:10.1371/journal.pone.0024730.g001
Focused Ultrasound-Induced Molecular Responses
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24730(Figure 1E and F). Threshold fluorescence intensity values were
obtained by imaging controls of each tissue type from mice that
did not receive FL-SPION and were immunostained without the
F4/80 primary antibody.
Monitoring FL-SPION-labeled macrophage infiltration by
MRI
Labeling macrophages with FL-SPION allowed non-invasive
monitoring of macrophage infiltration in vivo by clinically relevant
MRI at 3 Tesla. T2*-weighted MR images of mice that received
FL-SPION followed by either cFUS or pFUS to the leg were
acquired 3 and 8 days after treatment with FUS. Figure 2 shows
representative MR images demonstrating hypointense voxels in
the region of the leg that received FUS exposures that was not
detected in the contralateral untreated legs. Hypointense voxels
were detected after both cFUS or pFUS treatment at 3 days post-
FUS and persisted through 8 days post-FUS. Qualitatively,
hypointense voxels were clearly observed in cFUS-treated animals
on days 3 and 8 (Figure 2A and C), and pFUS-treated animals on
day 3 (Figure 2B). pFUS-treated animals on day 8 demonstrated a
more homogenous distribution of poorly-contrasted hypointensity
through the treated area (Figure 2D). T2-weighted images at the
same time points show evidence of edema as hyperintense voxels
in the treated legs of mice receiving cFUS, however, edema was
not detected in pFUS-treated mice (Figure 3).
Histological characterization of FUS-treated muscle and
quantification of macrophage infiltration
Prussian blue staining was performed on FUS-treated muscle
sections to detect FL-SPION-labeled macrophages 3 and 8 days
post-FUS (Figure 4). Animals receiving ablative cFUS exposures
were found to be necrotic with highly disorganized cytoarchitec-
ture compared to the contralateral limb (Figure 4C and D). In
mice that received pFUS, the morphological integrity was highly
preserved throughout the treatment volume (Figure 4A and B).
pFUS-treated muscle exhibited less necrosis than cFUS-treated
tissue at both days 3 and 8. Extensive hemorrhage was frequently
observed in all mice treated with cFUS. In contrast, only rare areas
of hemorrhage were noted following pFUS and evidence of
hemorrhage was not observed in all pFUS-treated mice (Figure
S1). These findings are consistent with a previous report in which
intact muscle fibers were observed to occur with increased gaps
between myofibrils [16]. Histological findings were unchanged
between days 3 and 8 for both pFUS- and cFUS-treated animals.
Macrophage infiltration into muscle was quantified by counting
Prussian blue-positive cells in the treatment volume. Five fields-of-
view (FOV) were analyzed using a 406objective to view similar
regions of the treatment volume from 3 animals per treatment
group. FUS treated muscles were compared to the untreated
contralateral leg in each mouse (Figure 5) (F7,23=36.34,
p,0.0001). The presence of macrophages was greater in both
cFUS- and pFUS-treated groups at days 3 and 8 when compared
to controls of the same day. Macrophage infiltration was not
statistically different between pFUS or cFUS treatment on day 3
(p.0.05). The number of observed macrophages in pFUS-treated
animals did decrease between days 3 and 8 (p,0.05). There was a
statistically insignificant trend for macrophage infiltration to
decrease between days 3 and 8 in mice receiving cFUS (p.0.05).
Effects of cFUS and pFUS on apoptosis
To further investigate whether pFUS exposures were destructive
to tissue, apoptotic nuclei were detected using a fluorescein-based
TUNELassay.MuscletissuesectionsfrompFUS- andcFUS-treated
Figure 2. Evaluation of FL-SPION-labeled macrophage migra-
tion to FUS-treated muscle tissue by MRI. T2*-weighted MR
images were obtained at 3T after 3 (A and B) and 8 (C and D) days
post-FUS. Imaging reveals hypointense voxels in regions of the right leg
that were treated with cFUS (A and C) or pFUS (B and D) exposures.
doi:10.1371/journal.pone.0024730.g002
Figure 3. Evaluation of FUS-treated muscle tissue by T2-
weighted MRI. T2-weighted MR images were obtained at 3T after 3
(A and B) and 8 (C and D) days post-FUS. Imaging reveals persistent
edema on days 3 and 8 in regions of the right leg that were treated with
cFUS exposures (A and C) but not pFUS exposures (B and D).
doi:10.1371/journal.pone.0024730.g003
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untreated contralateral legs. Apoptotic nucleiwere detected near the
margins of the treatment volume in animals receiving cFUS on both
days3 and 8 following treatment (Figure 6)and werenotobservedin
pFUS-treated mice. Sections from pFUS-treated mice resembled
those from control tissue.
Upregulation of cytokines, growth factors, and cell
adhesion molecules
To investigate the molecular responses that accompanied the
deposition of FUS energy (primarily thermal energy for cFUS and
mechanical energy for pFUS), we examined levels of signaling
molecules including cytokines, growth factors, and cell adhesion
molecules. For cytokine levels, homogenized muscle tissue was
analyzed using an ELISA-based cytokine array. Tissues from both
pFUS- and cFUS-treated animals (n=5) were analyzed for levels
of cytokines on days 0, 1, 3, and 7 following FUS exposures. To
assess local increases in cytokine levels, those in treated muscle
were compared to control muscle from the contralateral leg on the
same day. The data are summarized in Figure 7 and Figure S2 (see
Table S1 for statistical values). Two-way ANOVAs performed for
each cytokine revealed that both cFUS- and pFUS-treated muscle
tissue exhibited significant increases of several cytokines on days 0
and 1 following treatment, and in general, declined to control
levels by 3 days post-treatment.
The panel of cytokine expression differed somewhat between
cFUS and pFUS treatment. pFUS upregulated local expression of
the following cytokines on days 0 or 1 after treatment: IL-1a,I L -
1b, MCP-1, INFc,M I P - 1 a, granulocyte-macrophage colony-
stimulating factor (GMCSF), and RANTES. cFUS upregulated
expression IL-2, IL-6, IL-10, MCP-1, and INFc during the same
time period. Cytokine levels in treated tissue were identical to
those in the control tissue by day 3 after FUS treatment with the
exception of a modest elevation in IL-1a being observed 3 days
after pFUS. In pFUS-treated tissue, IL-4, IL-5, IL-6, IL-10, and
IL-17 were greater in treated tissue on days 0 and 1 than at days
3 or 7 (Figure S1). However, levels of these cytokines in treated
tissue on days 0 and 1 were not different than contralateral
muscle levels on days 0 and 1. This suggests the possibility of a
Figure 4. Prussian blue staining of FL-SPION-labeled macro-
phages in muscle tissue following FUS exposures. Muscle
following pFUS on days 3 (A) and 8 (B) post-treatment. pFUS-treated
tissue shows well preserved cytoarchitecture with increased gaps
between muscle fiber bundles and infiltration of macrophages (arrows).
Tissue exposed to cFUS is shown 3 (C) and 8 (D) days after. Large
amounts of necrosis and macrophage infiltration are seen with no
discernable histological integrity through the treatment volume.
Control untreated muscle is shown in (E). Scale bars represent 50 mm.
doi:10.1371/journal.pone.0024730.g004
Figure 5. Quantification of macrophage infiltration into muscle
following cFUS or pFUS. Muscle tissue treated with cFUS or pFUS
showed a greater number of Prussian blue positive macrophages than
control tissue on both days 3 and 8 post-FUS (5 FOV/animal, n=3).
Statistically similar numbers of macrophages were observed in pFUS-
and cFUS-treated tissue on day 3. A significant decrease (p,0.05) in
macrophages is observed between days 3 and 8 in pFUS-treated tissue,
but not in cFUS-treated tissue.
doi:10.1371/journal.pone.0024730.g005
Figure 6. Effect of FUS on apoptosis. Blue represents DAPI-stained
nuclei and green represents TUNEL-positive nuclei. No apoptotic nuclei
were observed on days 3 or 8 following pFUS or in untreated control
muscle at the same time points. However, several apoptotic nuclei were
observed near the margin of the cFUS treatment volume on both days 3
and 8 post-cFUS.
doi:10.1371/journal.pone.0024730.g006
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following pFUS.
We examined the local expression levels of chemotactic growth
factors in pFUS-treated tissue that are associated with inflamma-
tion, cell homing, and tissue regeneration. We examined
expression of these factors on days 0 and 1 post-treatment
(n=5)—during the window when cytokine levels were elevated
(Figure 8, Table S2). Western blotting showed significant increases
in expression of VEGF, FGF, SDF-1a, hepatocyte growth factor
(HGF), and placental growth factor (PLGF) in pFUS-treated tissue
within 24 hr following treatment when compared to the
contralateral leg. Of note, PDGF levels were not different in the
pFUS treated versus contralateral legs.
Another component of cellular infiltration into tissue is the
expression of signaling/adhesion molecules such as ICAM-1 and
VCAM-1, which are overexpressed on activated endothelial cells.
Dual fluorescence-immunostaining for ICAM-1 and VCAM-1 was
performed on tissue sections on days 0 and 1 following pFUS
treatment (Figure 9). Compared to contralateral control muscle,
the fluorescence images show pFUS treatment results in a modest
increase of VCAM along muscle fiber bundles on day 0, and
dramatically increased expression of both VCAM and ICAM in
vessels and muscle fibers on day 1.
Discussion
The major finding of this study is that pFUS exposures induced
an array of molecular biological changes in muscle tissue and
infiltration of macrophages without detectable destruction to
exposed tissue. By pre-labeling splenic macrophages with FL-
SPION, we were able to non-invasively track the infiltration of
macrophages to the exposure site by histology and T2*-weighted
MRI. pFUS exposures induce a short-lived molecular response in
treated muscle including the upregulation of cytokines, growth
factors, and adhesion molecules.
Figure 7. Expression of proinflammatory cytokines in muscle following cFUS or pFUS. Levels of each cytokine in muscle treated with cFUS
or pFUS (n=5) was compared to the control tissue of the same day. Most cytokine elevations were short-lived and returned to control levels by day 3.
doi:10.1371/journal.pone.0024730.g007
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of pFUS exposures have been incomplete and not specifically
focused on factors regulating cellular homing [10,15,16,17].
Histologically, pFUS exposures in the brain were shown to
produce indiscrete lesions [10,17]. Post FUS, limited extravasation
of red blood cells and infiltration of macrophages were observed
persisting up to 4 weeks, and did not appear do induce significant
amounts of neuronal damage, necrosis, or apoptosis [10]. pFUS
exposures to the brain have been shown to increase BBB
permeability through the disruption of endothelial tight junctions
[17]. pFUS exposures to the muscle were shown to transiently
increase tissue permeability through enlargement of gaps between
muscle fiber bundles and improve convective transport of locally-
injected nanoparticles [16]. Our study agrees with previous
findings in muscle that suggest pFUS, unlike cFUS, can be
applied to tissue without observed destruction to the tissue [9,16].
In the current study, the hamstring muscle did not exhibit
deleterious effects in response to pFUS, whereas major myofiber
disorganization, necrosis, and apoptosis were observed with cFUS.
pFUS resulted in enlarged gaps between muscle fibers with some
small amount of hemorrhage through 8 days of this study.
Macrophage infiltration following pFUS was similar to that cFUS
treatment on day 3, but significantly reduced by day 8 in pFUS-
treated tissue compared to cFUS-treated tissue. By day 3 post-
pFUS, edema was not detectable by T2-weighted MRI unlike
Figure 8. Expression of growth factors on days 0 and 1 following pFUS treatment. Western blotting was used to compare growth factor
expression in pFUS-treated muscle compared to muscle from the untreated contralateral leg (n=5).
doi:10.1371/journal.pone.0024730.g008
Figure 9. Expression of ICAM-1 and VCAM-1 in muscle tissue
on days 0 and 1 following pFUS. Blue represents DAPI stained
nuclei, green represents ICAM-1, red represents VCAM-1, and yellow
represents merged ICAM-1 and VCAM-1. Compared to control, there is
slight increase of VCAM-1 on day 0 and dramatic increase of both ICAM-
1 and VCAM-1 on day 1 post-pFUS.
doi:10.1371/journal.pone.0024730.g009
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treatment did not induce apoptosis that was observed in cFUS-
treated tissue, especially near the margins of the treatment volume.
Relatively little is known about the biochemical and molecular
biological changes following pFUS. One previous study conducted
a gene array analysis on muscle treated with pFUS and revealed
upregulation in a variety of genes, including some involved in
inflammation and cell homing processes [18]. The pFUS used in
that study [18] deposited approximately 65 times more total
energy to tissue than exposures described in the current study and
elsewhere [16]. Furthermore, the authors of that study [18]
observed significant necrosis and disorganization of muscle tissue.
Molecular responses to lower-power pFUS exposures, where tissue
destruction was not observed, have heretofore not been described.
The mechanical disruptions of pFUS exposure triggers an acute
and short-lived cascade of cytokines and growth factors that are
involved in macrophage infiltration, wound healing, and anti-
inflammatory responses. Significant interactions occur between
many of the upregulated cytokines in skeletal muscle [For Review
see [19]]. For example, TNFa and INFc upregulate expression of
ICAM and VCAM [20,21] while TNFa can also stimulate local
release of IL-1b, which in turn, also increases ICAM and VCAM
[22] expression on the surfaces of endothelial cells. IL-1b also
activates endothelial cells to secrete GMCSF [23] whereas it has
been shown that MIP-1a recruits circulating monocytes to tissue
[24]. MCP-1 is involved in recruitment and activation of
macrophages [25]. In response to pFUS exposures, several growth
factors are also expressed to facilitate homing of immune cells and
tissue regeneration. HGF and FGF enhance myoblast proliferation
while HGF also increases myoblast migration into the injured area
[26,27]. VEGF and PLGF stimulate angiogenesis [28,29] along
with SDF-1a [30], and can recruit muscle progenitor cells from
bone marrow [31]. In the current study ICAM and VCAM were
upregulated in the pFUS-treated muscle suggesting that mechan-
otransduction may have induced these changes as well as the
cytokine expression, which result in the movement of macrophages
and other cells into interstitial spaces [32].
Mechanotransduction from pFUS exposures stimulates vigorous
molecular responses that may be associated with inflammation,
tissue repair, and cell homing without significant tissue destruction,
and potentially may have great clinical value. Low-intensity (i.e.,
therapeutic) ultrasound using microbubble contrast agents has
been shown effective in accelerating hyperemia blood flow in
skeletal muscle after ischemic events with some evidence it also
promotes remodeling of the microvasculature [33]. Inducing
mechanotransduction in a non-destructive way may be a reliable
technique to target homing of cell-based therapies. For example,
bone marrow stromal cells or mesenchymal stem cells (BMSC) are
capable of either actively or passively homing to sites of
inflammation where local cytokine gradients are present, but is
often inefficient with regard to the number of cells reaching these
regions [34,35]. pFUS exposures essentially provide a way to
modulate, both spatially and temporally, the expression of pro-
homing factors in tissues. Energy from pFUS can be accurately
deposited deep in the body, is safe, and a readily translatable
technology to the clinic. An additional advantage of this treatment
modality (cFUS or pFUS) is the relatively small size of the focal
zone (typically 1 mm61m m 610 mm), where acoustic energy is
concentrated. This renders FUS highly specific in regards to
targeting. For example, treatment of prostate tumors can currently
be carried out without destructive effects in sensitive structures
such as the neurovascular bundle [36].
The results of the present study suggest that pFUS exposures
may be an ideal way to target homing of stem cells at a desired
time and to a desired location by increasing local expression of
molecular cues. The acute release of cytokines and growth factors
from muscle following pFUS indicates that molecular changes
occur as a result of non-thermal radiation forces. This, coupled
with the apparently non-destructive manner in which energy is
deposited could potentially be used to enhance tropism of cells to
target tissue. We have observed in a preliminary study, increased
BMSC migration to kidneys as a result of pFUS treatment
compared to the untreated contralateral kidney (unpublished
results). Several aspects of this phenomenon require further
investigation including determining if pFUS can stimulate
additional stem cell homing to target tissue during active
inflammation or pathology. Furthermore, molecular characteriza-
tion in other tissues following pFUS is needed. Specifically, we seek
to understand if multiple pFUS exposures to the same site can
reestablish pro-homing factor gradients within tissue once they
have decayed back to baseline following initial exposures or after
acute inflammation from pathology has subsided. Especially of
importance, is whether pFUS exposures can establish chemokine
gradients in pathological models after the acute inflammatory
window has closed, which potentially frees cellular therapeutics
from the necessity to be administered during this early time period.
These investigations are ongoing in the laboratory.
Materials and Methods
Animals
All animal procedures were done in accordance the Animal
Care and Use Committee of the Clinical Center at our institution.
Female C3H mice (,16 weeks of age) were housed with free
access to food and water and were allowed to reach a weight of
.28 g before FUS exposures. Mice were administered a tail vein
injection of Molday ION Rhodamine-B SPION (8 mg/kg bw,
BioPAL, Worcester, MA) 72 h prior to FUS treatment, and hair
on both legs was removed with depilatory cream 24 h prior.
FUS
A single treatment of FUS was administered to the right legs of
mice using a modified Sonoblate 500 system (Focus Surgery,
Indianapolis, IN) described previously [16]. The probe was
comprised of both a spherical, concave therapeutic transducer
(diameter, 5 cm; focal length, 4 cm; operating frequency, 1 MHz;
max power output, 120 W) and a collinear imaging transducer
(aperture, 8 mm; operating frequency, 10 MHz). During the
procedure mice were anesthetized with isoflurane (2.5% in O2)
and placed in a restrainer with their legs submerged in degassed
H2O maintained at 37uC. Mice were positioned under imaging-
ultrasound guidance such that therapeutic exposures were aimed
at the right hamstring muscle. Therapeutic FUS was performed
across the hamstring with a raster pattern of a 263 matrix in the
X–Y plane (i.e. perpendicular to the direction of ultrasound
propagation) with elemental spacing of 2 mm. For pulsed
exposures, each of the 6 foci received 100 cycles of FUS using
the following exposure parameters: acoustic power, 40 W; pulse
repetition frequency, 1 Hz; duty cycle, 5% (50 ms ‘‘on’’ and
950 ms ‘‘off’’). The total exposure time per raster point was
1.67 min. cFUS exposures were set up in an identical manner, but
each focal point received a single pulse lasting 4 s at 100 W. The
spatial average, temporal peak intensity (ISATP) of pFUS and cFUS
exposures was 2660 W/cm
2 and 6650 W/cm
2, respectively. The
spatial average, temporal average intensity (ISATA) was the same as
the ISATP for the cFUS exposures, but was 133 W/cm
2 for the
pFUS exposures. The total energy deposited by pFUS and cFUS
exposures was 1.33610
4 J and 2.67610
4 J, respectively.
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following basis: they have been shown to enhance the delivery of
nanoparticles tomuscle whileminimizing the thermal effectsofFUS
(generating temperature changes between 2–4uC). cFUS exposures
were designed to generate similar effects observed with tumor
ablation in clinical treatments (9). Mice wereeuthanized at 4 h,1, 3,
and 7 or 8 days after FUS treatment. The vasculature of the mouse
was perfused with 0.9% saline or 4% paraformaldehyde in PBS
(pH 7.4) through the left ventricle. A portion of the right atrium was
excised the mouse was perfused until clear perfusate emerged from
the right atrium. Left and right hamstrings, spleens, and livers were
collected and used for molecular and histological analyses.
Immunohistochemistry
Tissue was immersed in 4% paraformaldehyde in PBS (pH 7.4)
overnight at 4uC. Tissue was embedded in paraffin and sectioned
at a thickness of ,10 mm and mounted onto positively-charged
slides. Paraffin was removed in xylene and tissue was rehydrated in
graded ethanol concentrations. Tissues were washed extensively
with PBS containing 0.05% Tween-20 (TPBS). Heat induced
epitope retrieval (HIER) was performed by microwaving tissue for
4 min in HIER-citrate buffer. Tissue was allowed to cool and then
was treated with SuperBlock (Pierce Biotechnology, Rockford, IL)
for 5 min and rinsed with TPBS. Tissues were incubated with
primary at a 1:50 dilution in TPBS overnight at 4uC. Primary
antibodies against ICAM and F4/80 were rat anti-mouse IgG and
antibodies against VCAM were rabbit anti-mouse IgG. Tissue was
rinsed extensively in TPBS and then incubated in the dark for 2 hr
at room temperature with an AlexaFluor 488-conjugated goat
anti-rat IgG or AlexaFluor 546-conjugated goat anti-rabbit IgG as
a secondary antibody. Tissues were again washed thoroughly with
TPBS and #1-glass coverslips were affixed using ProLong Gold
antifade reagent with DAPI (Invitrogen).
Confocal Microscopy
Muscle sections were examined using an upright laser scanning
confocal microscope (series 710, Zeiss, Oberkochen, Germany)
using Plan-Apochromat objectives (206 air, N.A.=0.8; 636 oil-
immersion, N.A.=1.4). Illumination was provided by an argon-
ion (Lasos, Jena, Germany), diode, and diode-pumped solid-state
lasers (Roithner Lasertechnik, Vienna, Austria). Excitation for
DAPI, Fluorescein/AlexaFluor488, and Rhodamine-B/Alex-
Fluor546 was performed using laser lines at 405 nm, 488 nm,
and 561 nm, respectively. Fluorescence emission was filtered using
a short-pass (495 nm), band-pass (494–542 nm), and long-pass
(566 nm) filters appropriate for each fluorophore. Fluorescence
images were acquired sequentially to minimize cross-talk.
MRI
Mice were imaged on a 3T clinical scanner (Acheva, Philips
Healthcare, Andover, MA) using a 4 cm solenoid receive-only coil
(Philips Research Laboratories, Hamburg, Germany). T2*-weight-
ed images were acquired with the following instrumental settings:
repetition time (TR), 430 ms; echo time (TE), 15 ms; flip angle,
30u; number of signal acquisitions (NSA), 4. T2-weighted images
were acquired during the same imaging sessions. Dual-echo, turbo
spin echo (TSE) images were acquired with the following
instrumental settings: TR, 2128 ms; TE, 10 and 50 ms; echo
train length (ETL), 6; number of averages=3. Images were
obtained with a 5 cm field-of-view and 0.5 mm slice thickness.
Images were reconstructed using 512 6512 pixels.
Prussian Blue Staining
Fixed tissue sections were deparaffinized and rehydrated as
described above. Prussian Blue staining was done by incubation in
10% potassium ferrocyanide and 10% hydrochloric acid for
30 min. Slides were then washed extensively in deionized water
and counterstained with Nuclear Fast Red (Scytek, Logan, UT) for
3 min. Slides were dehydrated in graded ethanol and xylene and
#1-glass coverslips were affixed using Permount mounting
medium. Slides were examined on an Axioplan Imaging II
microscope (Zeiss) illuminated with an X-cite mercury light source
(model 120Q, Lumen Dynamics, Mississauga, ON) using 206air
(N.A.=0.75) and 406oil immersion (N.A.=1.4) objectives.
TUNEL Staining
Apoptotic cells were detected in deparaffinized tissue sections
using a fluorescein-based in situ cell death detection kit (Roche
Applied Science, Indianapolis, IN) according to manufacturer’s
protocols. Sections were imaged by confocal microscopy for the
presence of fluorescein-positive nuclei.
Cytokine Array Analysis
Harvested hamstring muscle was homogenized in cell lysis
buffer (Roche Applied Science) containing protease inhibitor
cocktail (Santa Cruz Biotechnology, Santa Cruz, CA) at 4uC.
Samples were centrifuged at 15,000 rpm for 20 min at 4uC. The
supernatant of each sample was collected and used for analysis.
Total protein content of each sample was determined using a
bicinchoninic acid assay (Pierce Biotechnology). Cytokine levels
for pFUS-treated and untreated tissue were measured using a 16-
plex Mouse Cytokine Screen (Quansys Biosciences, Logan, UT).
The assay was performed according to manufacturer’s protocols
with each sample at a protein concentration of 3 mg/mL.
Luminescence was measured on an ImageStation 4000R Pro
(Carestream Molecular Imaging, Woodbridge, CT) using an
exposure time of 5 min.
Western Blotting
Protein samples (50 mg) were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under
reducing conditions on Novex Bis-Tris gels (4–12% acrylamide,
Invitrogen) and then transferred to polyvinylidene fluoride (PVDF)
membranes. Membranes were blocked using 5% bovine serum
albumin (BSA) in TBS+0.05% Tween-20 (TTBS) at room
temperature for 1 hr. Membranes were hybridized with rabbit
anti-mouse IgG primary antibodies against vascular endothelial
growth factor (VEGF), fibroblast growth factor (FGF), platelet
derived growth factor BB (PDGF-BB), placental growth factor
(PLGF), hepatocyte growth factor (HGF), and stromal cell derived
growth factor 1a (SDF-1a) overnight at 4uC in TTBS containing
5% BSA. All primary antibodies were from Abcam (Cambridge,
MA) and were used at a 1:1000-fold dilution from manufacturer’s
stocks. Hybridization with a secondary antibody was done for 1 hr
at room temperature using a horseradish peroxidase (HRP)-
conjugated, donkey anti-rabbit-IgG antibodies at a 1:5000 dilution
from manufacturer’s stock (GE Healthcare, Little Chalfont, UK).
Blots were developed by incubation with enhanced chemilumi-
nescence reagents (Invitrogen) for 2 min at room temperature and
imaged with an ImageStation 4000R Pro (Carestream Molecular
Imaging) with exposure times ranging from 1–10 min. Loading
controls were performed with Ponceau-S staining of the
membranes.
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Qualitative data analyses were performed by researchers in a
blinded fashion. Quantiative values are presented as the
mean6S.D. Comparison of means was done using a two-way
analysis of variance (ANOVA) followed by Bonferroni’s post-test
or a Student’s t-test with a Bonferroni correction using Prism
software (v. 5.0, GraphPad Software, La Jolla, CA). A p-
value,0.05 was considered significant.
Supporting Information
Figure S1 Prussian blue staining of FL-SPION-labeled macro-
phages in muscle tissue following FUS exposures. Muscle after
cFUS (A) and pFUS (B) 3 days post-treatment. Using Nuclear Fast
Red as a counterstain, anuclear red blood cells are indicated by
arrows and appear as small disc-like structures with faint or no
staining. Extensive hemorrhage is frequently observed in cFUS-
treated tissue (A), while rarely and minimally noted in pFUS-
treated tissue. Scale bars represent 50 mm.
(TIF)
Figure S2 Expression of proinflammatory cytokines in muscle
following cFUS or pFUS. Levels of each cytokine in treated muscle
were not statistically different compared to the control tissue of the
same day. ANOVA analyses did reveal that expression of IL-4, IL-
5, and IL-17 in pFUS-treated tissue was elevated on days 0 and 1
compared to pFUS-treated tissue on days 3 and 7 even though no
differences were observed between treated and control tissue on
days 0 and 1. This finding may suggest a systemic increase of these
cytokines on days 0 and 1 in response to pFUS exposures.
(TIF)
Table S1 Statistical analysis of cytokine array data following
cFUS or pFUS.
(DOCX)
Table S2 Statistical analysis of expression of growth factors
following pFUS.
(DOCX)
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